Effects of cyclooxygenase inhibition on bone, tendon, and ligament healing
The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
Cyclooxygenases (COX-1 and COX-2) catalyze the conversion of arachidonic acid to prostaglandins (PGs). PGs play a significant role in bone metabolism in health and disease. Conventional non-selective, non-steroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors (COXIBs) are widely used in patients with musculoskeletal conditions and as a post-surgical analgesics. Due to their effects on PG synthesis, these drugs have been hypothesized to affect the healing process of bone fractures and orthopedic surgical sites. A variety of experimental models of bone, ligament, and tendon repair have assessed the effects of these selective and non-selective COX inhibitors in animals, but with variable outcomes. At this time, large-scale, robust clinical study data do not exist, limiting the relevant assessment of experimental animal data to humans. Here, we provide a critical review of available data on the role of PGs and the effect of COX inhibitors on bone, tendon, and ligament repair. Collectively, this assessment suggests potential involvement of PGs in the healing process of these tissues via modulation by non-selective NSAIDs and selective COX-2 inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, given their inhibitory effects on ligament healing, resulting in the inferior histological, biochemical, and biomechanical properties of ligaments [22,23,24,25,26], many experts now caution against their use for treating ligament injuries, especially in athletes [27,28].”
From Mesenchymal Stem Cells for Enhanced Healing of the Medial Collateral Ligament of the Knee Joint (2023) · cites this paper as [24]
Citations
Cites
1 retracted
THE EFFECT OF CYCLOOXYGENASE-2 INHIBITION ON ANALGESIA AND SPINAL FUSION
REUBEN, S. S., & EKMAN, E. F. (2005) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200503000-00009 · Cited by 112 · cited 2×
“Rofecoxib and naproxen impaired bone in-growth in rabbit tibia at comparable levels, while ketorolac, another non-selective NSAID, impaired bone fracture healing in rats to a greater extent then did the selective COX-2 inhibitor, parecoxib (valdecoxib prodrug), which caused only a minor delay in fracture healing at do…”
BackgroundRetractedThe Cell and Molecular Biology of Fracture Healing
Einhorn, T. A. (1998) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199810001-00003 · Cited by 1,278 · cited 1×
“In adults, bone formation includes the recruitment, proliferation, and differentiation of mesenchymal stem cells with endochondral and intramembranous bone ossifi cation [28, 43].”
BackgroundGerstenfeld, L. C., Cullinane, D. M., Barnes, G. L., Graves, D. T., & Einhorn, T. A. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10435 · Cited by 1,243 · cited 5×
“In the infl ammatory stage of healing, PGs, particularly PGE2, are abundantly produced by osteoblasts and accumulate in the fracture callus, creating a rich microenvironment of PG activity [1, 31, 32].”
BackgroundInfluentialAllometric Scaling of M-Mode Cardiac Measurements in Normal Adult Dogs
Cornell, C. C., Kittleson, M. D., Torre, P. D., Häggström, J., Lombard, C. W., Pedersen, H. D., Vollmar, A., & Wey, A. (2004) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2004.tb02551.x · Cited by 811
Mesenchymal stem cells in bone development, bone repair, and skeletal regenaration therapy
Bruder, S. P., Fink, D. J., & Caplan, A. I. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240560303 · Cited by 716
Zhang, X., Schwarz, E. M., Young, D. A., Puzas, J. E., Rosier, R. N., & O’Keefe, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215681 · Cited by 577 · cited 3×
“Therefore, the relevance of COX-2 gene ablation in mice to clinical effects of pharmacological inhibition of COX-2 on bone healing remains undefi ned [30].”
BackgroundCyclo-Oxygenase 2 Function Is Essential for Bone Fracture Healing
Simon, A. M., Manigrasso, M. B., & O'Connor, J. P. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.963 · Cited by 530 · cited 1×
“In COX-2 knockout models, effects on bone fracture healing included impaired fracture healing and decreased bone density, reduced bone resorption and osteoclast formation, and lack of infl ammatory response [3, 108].”
BackgroundRegulatory mechanisms in the pathways of cartilage and bone formation
de Crombrugghe, B., Lefebvre, V., & Nakashima, K. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00276-3 · Cited by 461 · cited 2×
“In intramembranous bone ossifi cation, the mesenchymal cells differentiate directly into osteoblasts [44].”
BackgroundSuzawa, T., Miyaura, C., Inada, M., Maruyama, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S., & Suda, T. (2000) · Endocrinology · doi:10.1210/en.141.4.1554 · Cited by 415
Forwood, M. R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111112 · Cited by 358 · cited 4×
“In humans, impact loading was associated with an increased production of PG, a result abrogated by NSAIDs and COX-2 inhibitors [23, 24].”
BackgroundInfluentialGerstenfeld, L. C., Thiede, M., Seibert, K., Mielke, C., Phippard, D., Svagr, B., Cullinane, D., & Einhorn, T. A. (2003) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(03)00003-2 · Cited by 348
Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation
Yoshida, K., Oida, H., Kobayashi, T., Maruyama, T., Tanaka, M., Katayama, T., Yamaguchi, K., Segi, E., Tsuboyama, T., Matsushita, M., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062053399 · Cited by 345
Allen, H. L., Wase, A., & Bear, W. T. (1980) · Acta Orthopaedica Scandinavica · doi:10.3109/17453678008990848 · Cited by 295
The role of prostaglandins in the regulation of bone metabolism.
Kawaguchi, H., Pilbeam, C. C., Harrison, J. R., & Raisz, L. G. (1995) · PubMed · Cited by 293
Huo, M. H., Troiano, N. W., Pelker, R. R., Gundberg, C. M., & Friedlaender, G. E. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090310 · Cited by 240
Tsukii, K., Shima, N., Mochizuki, S.-I., Yamaguchi, K., Kinosaki, M., Yano, K., Shibata, O., Udagawa, N., Yasuda, H., Suda, T., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8610 · Cited by 238 · cited 4×
“Collectively, there is abundant evidence to support a signifi cant role of PGs in bone metabolism in health and disease, which can be modulated by exogenous administration of PGs. PGE2 and its receptors, EP2R and EP4R, appear to be the main contributors to bone metabolism.”
BackgroundInfluentialEffect of Nonsteroidal Antiinflammatory Drugs on Fracture Healing: A Laboratory Study in Rats
Altman, R. D., Latta, L. L., Keer, R., Renfree, K., Hornicek, F. J., & Banovac, K. (1995) · Journal of Orthopaedic Trauma · doi:10.1097/00005131-199505000-00006 · Cited by 236
Effect of Indomethacin on Fracture Healing in Rats
Rø, J., Sudmann, E., & Marton, P. F. (1976) · Acta Orthopaedica Scandinavica · doi:10.3109/17453677608988744 · Cited by 230
Onoe, Y., Miyaura, C., Kaminakayashiki, T., Nagai, Y., Noguchi, K., Chen, Q. R., Seo, H., Ohta, H., Nozawa, S., Kudo, I., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.2.758 · Cited by 211 · cited 1×
“It has been suggested that COX-2 and associated PG synthesis, when stimulated by parathyroid hormone (PTH), plays a critical role in advancing bone resorption, while cytokines, such as IL-13 and IL-4, inhibit resorption, emphasizing the role of local environment in production of COX-2 and PGs [3, 35].”
BackgroundImpaired Bone Resorption to Prostaglandin E2 in Prostaglandin E Receptor EP4-knockout Mice
Miyaura, C., Inada, M., Suzawa, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S., & Suda, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002079200 · Cited by 208
The Effects of Nonsteroidal Anti-inflammatory Drugs on Posterior Spinal Fusions in the Rat
Dimar, J. R., Ante, W. A., Zhang, Y. P., & Glassman, S. D. (1996) · Spine · doi:10.1097/00007632-199608150-00006 · Cited by 195
The in vivo anabolic actions of prostaglandins in bone
Jee, W. S. S., & Ma, Y. F. (1997) · Bone · doi:10.1016/s8756-3282(97)00147-6 · Cited by 194 · cited 1×
“PGE2 has also been shown to add bone-to-bone envelopes and to induce woven bone formation [8].”
BackgroundProstaglandins and bone: physiology and pathophysiology
Raisz, L. G. (1999) · Osteoarthritis and Cartilage · doi:10.1053/joca.1998.0230 · Cited by 184
Dekel, S., Lenthall, G., & Francis, M. (1981) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.63b2.7217139 · Cited by 176 · cited 2×
“PGs are abundantly produced by osteoblasts and are increased in fracture callus during the fi rst 2 weeks following injury [1, 31, 32].”
BackgroundCOX‐2 selective NSAID decreases bone ingrowth in vivo
Goodman, S., Ma, T., Trindade, M., Ikenoue, T., Matsuura, I., Wong, N., Fox, N., Genovese, M., Regula, D., & Smith, R. L. (2002) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(02)00079-7 · Cited by 174
Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes
Geng, Y., Blanco, F. J., Cornelisson, M., & Lotz, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.796 · Cited by 168 · cited 1×
“Increased COX-2 expression by osteoblasts and cementoblasts has also been observed in deep periodontal tissue after application of lipopolysaccharide and in activated human articular chondrocytes [51, 55].”
BackgroundKnockout of the Murine Prostaglandin EP2 Receptor Impairs Osteoclastogenesis in Vitro
Li, X. (2000) · Endocrinology · doi:10.1210/en.141.6.2054 · Cited by 164
Tai, H., Miyaura, C., Pilbeam, C. C., Tamura, T., Ohsugi, Y., Koishihara, Y., Kubodera, N., Kawaguchi, H., Raisz, L. G., & Suda, T. (1997) · Endocrinology · doi:10.1210/endo.138.6.5192 · Cited by 163
Topical NSAIDs for Musculoskeletal Conditions: A Review Of The Literature
Vaile, J. H., & Davis, P. J. (1998) · Drugs · doi:10.2165/00003495-199856050-00004 · Cited by 162
Aspirin and NSAID use in older women: Effect on bone mineral density and fracture risk
Bauer, D. C., Orwoll, E. S., Fox, K. M., Vogt, T. M., Lane, N. E., Hochberg, M. C., Stone, K., & Nevitt, M. C. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110106 · Cited by 141
Carbone, L. D., Tylavsky, F. A., Cauley, J. A., Harris, T. B., Lang, T. F., Bauer, D. C., Barrow, K. D., & Kritchevsky, S. B. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.10.1795 · Cited by 135
Parecoxib Impairs Early Tendon Repair but Improves Later Remodeling
Virchenko, O., Skoglund, B., & Aspenberg, P. (2004) · The American Journal of Sports Medicine · doi:10.1177/0363546504263403 · Cited by 132
Basic Fibroblast Growth Factor Induces Osteoclast Formation in Murine Bone Marrow Cultures
Hurley, M. M., Lee, S. K., Raisz, L. G., Bernecker, P. M., & Lorenzo, J. A. (1998) · Bone · doi:10.1016/s8756-3282(97)00292-5 · Cited by 129 · cited 1×
“NS-398 inhibited bone formation in response to mechanical loading and osteoclast formation following stimulation with b-FGF [23, 59, 60].”
BackgroundTHE EFFECT OF CYCLOOXYGENASE-2 INHIBITORS ON SPINAL FUSION
LONG, J., LEWIS, S., KUKLO, T., ZHU, Y., & RIEW, K. D. (2002) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200210000-00004 · Cited by 126 · cited 2×
“However, celecoxib did not signifi cantly inhibit the rate of spinal fusion in rats, rabbits, or humans; whereas indomethacin showed biomechanical and radiographic evidence of delayed healing at 4 weeks postsurgery [74, 110].”
BackgroundSakuma, Y., Tanaka, K., Suda, M., Yasoda, A., Natsui, K., Tanaka, I., Ushikubi, F., Narumiya, S., Segi, E., Sugimoto, Y., et al. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.2.218 · Cited by 121
Ringel, R., Brenner, J. I., Haney, P. J., Burns, J. E., Moulton, A. L., & Berman, M. A. (1982) · Radiology · doi:10.1148/radiology.142.3.7199748 · Cited by 120
A Cyclooxygenase-2 Inhibitor Impairs Ligament Healing in the Rat
Elder, C. L., Dahners, L. E., & Weinhold, P. S. (2001) · The American Journal of Sports Medicine · doi:10.1177/03635465010290062101 · Cited by 115 · cited 1×
“ment in rats, was associated with a 32 % lower load to failure on day 14 compared to untreated/transected ligaments [106].”
BackgroundHigh, W. B. (1987) · Bone · doi:10.1016/8756-3282(87)90068-8 · Cited by 114 · cited 1×
“In dogs, subcutaneous administration of PGE2 resulted in cancellous and cortical bone formation and increased skeletal turnover [46, 47].”
BackgroundEvidence for a Direct Role of Cyclo-Oxygenase 2 in Implant Wear Debris-Induced Osteolysis
Zhang, X., Morham, S. G., Langenbach, R. I., Young, D. A., Xing, L., Boyce, B. F., Puzas, E. J., Rosier, R. N., O’Keefe, R. J., & Schwarz, E. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.4.660 · Cited by 113
Li, J., Burr, D. B., & Turner, C. H. (2002) · Calcified Tissue International · doi:10.1007/s00223-001-1025-y · Cited by 112 · cited 3×
“In comparison, NS-398 had no effect on periosteal bone formation in the rat tibia [23, 48].”
BackgroundInhibition of fracture healing by indomethacin in rats
Sudmann, E., Dregelid, E. B., Bessesen, A., & Mørland, J. G. (1979) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1979.tb00893.x · Cited by 111
Indomethacin-Induced Inhibition of Haversian Remodelling in Rabbits
Sudmann, E., & Bang, G. (1979) · Acta Orthopaedica Scandinavica · doi:10.3109/17453677908991283 · Cited by 109
Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer
Mohammed, S. I., Khan, K. N. M., Sellers, R. S., Hayek, M. G., DeNicola, D. B., Wu, L., Bonney, P. L., & Knapp, D. W. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.10.002 · Cited by 108 · cited 2×
“However, in diseased canine bone, COX-1 was present in 8 out of 13 osteosarcoma tumors in dog, while COX-2 was present in 3 out of the 13 tumors, suggesting a role for COX-2 in neoplastic bone conditions [52].”
BackgroundLi, X., Pilbeam, C. C., Pan, L. C., BREYER, R. M., & Raisz, L. G. (2002) · Bone · doi:10.1016/s8756-3282(02)00683-x · Cited by 104
Indomethacin and celecoxib improve tendon healing in rats
Forslund, C., Bylander, B., & Aspenberg, P. (2003) · Acta Orthopaedica Scandinavica · doi:10.1080/00016470310017802 · Cited by 103 · cited 1×
“Likewise, indomethacin signifi cantly increased tensile strength at 16 weeks after tenotomy of plantaris longus tendons in rabbits, but did not change the total collagen content [116].”
BackgroundLi, X. J., Jee, W. S. S., Li, Y. L., & Patterson‐Buckendahl, P. (1990) · Bone · doi:10.1016/8756-3282(90)90091-c · Cited by 103 · cited 1×
“In dogs, subcutaneous administration of PGE2 resulted in cancellous and cortical bone formation and increased skeletal turnover [46, 47].”
BackgroundMarsolais, D., Côt́e, C. H., & Frenette, J. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000078688.07696.ac · Cited by 101
Bone repair inhibited by indomethacin: Effects on bone metabolism and strength of rabbit osteotomies
Keller, J. O., Biinger, C., Andreassen, T. T., Bak, B., & Lucht, U. (1987) · Acta Orthopaedica Scandinavica · doi:10.3109/17453678709146360 · Cited by 101
Kulick, M. I., Smith, S., & Hadler, K. (1986) · The Journal Of Hand Surgery · doi:10.1016/s0363-5023(86)80116-2 · Cited by 100 · cited 1×
“Following Achilles tendon transection in rats, fl urbiprofen resulted in better organization of extracellular collagenous matrix, but decreased cross-sectional area and failure load [114].”
BackgroundFeyen, J. H. M., van der Wilt, G. J., Moonen, P., Bon, A. D., & Nijweide, P. J. (1984) · Prostaglandins · doi:10.1016/0090-6980(84)90034-0 · Cited by 98
Høgevold, H. E., Grøgaard, B., & Reikerås, O. (1992) · Acta Orthopaedica Scandinavica · doi:10.1080/17453679209169718 · Cited by 96
Thorsen, K., Kristoffersson, A. O., Lerner, U. H., & Lorentzon, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119061 · Cited by 95 · cited 2×
“In humans, impact loading was associated with an increased production of PG, a result abrogated by NSAIDs and COX-2 inhibitors [23, 24].”
BackgroundDifferential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae
Suponitzky, I., & Weinreb, M. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560051 · Cited by 92
Kawaguchi, H., Chikazu, D., Nakamura, K., Kumegawa, M., & Hakeda, Y. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.3.466 · Cited by 88 · cited 2×
“from cultured mouse calvariae with an order of potency indicating COX-2 as the primary actor [60].”
BackgroundNo effects of piroxicam on osteopenia and recovery after Colles' fracture
Adolphson, P., Abbaszadegan, H., Jonsson, U., Dal�n, N., Sj�berg, H. E., & Kal�n, S. (1993) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/bf00449987 · Cited by 87 · cited 1×
“Similarly, piroxicam did not decrease the rate of fracture healing in postmenopausal women with a displaced Colles’ fracture, but actually reduced the osteopenia caused by external fi xation [103, 104].”
BackgroundTranscriptional Regulation of the Cyclooxygenase-2 Gene by Diverse Ligands in Murine Osteoblasts
Wadleigh, D. J., & Herschman, H. R. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1606 · Cited by 86
Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease
Raisz, L. G. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00684-7 · Cited by 85
Cyclooxygenase-2 Expression in Canine Appendicular Osteosarcomas
Mullins, M. N., Lana, S. E., Dernell, W. S., Ogilvie, G. K., Withrow, S. J., & Ehrhart, E. J. (2004) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2004.tb02633.x · Cited by 85 · cited 1×
“In addition, the involvement of COX-2 in other neoplasia and bone sarcomas is well documented [53, 54].”
BackgroundCOX inhibitors and their effects on bone healing
Gerstenfeld, L. C., & Einhorn, T. A. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.2.131 · Cited by 83
The Effect of Cyclooxygenase-2 Inhibitors on Bone Healing
Gajraj, N. M. (2003) · Regional Anesthesia & Pain Medicine · doi:10.1016/j.rapm.2003.09.001 · Cited by 82
Kjærsgaard‐Andersen, P., Nafei, A., Teichert, G., Kristensen, O., Schmidt, S. A., Keller, J. O., & Lucht, U. (1993) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679308994587 · Cited by 82
Increased bone growth by local prostaglandin E2 in rats
Yang, R., Liu, T., & Lin‐Shiau, S. (1993) · Calcified Tissue International · doi:10.1007/bf00675627 · Cited by 81 · cited 2×
“PGE2 is the most potent agonist that stimulates bone resorption and formation [17].”
BackgroundThe Effect of Indomethacin Upon Experimental Fractures in the Rat
Elves, M. W., Bayley, I., & Roylance, P. J. (1982) · Acta Orthopaedica Scandinavica · doi:10.3109/17453678208992176 · Cited by 74 · cited 1×
“In older rats (6–9 months), high doses of indomethacin were associated with histological evidence of increased fi brogenesis and decreased osteogenesis and remodelling of bone fractures [93].”
BackgroundFracture healing in rats inhibited by locally administered indomethacin
Engesaeter, L. B., Sudmann, B., & Sudmann, E. (1992) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679209154794 · Cited by 72
Norrdin, R. W., & Shih, M. S. (1988) · Calcified Tissue International · doi:10.1007/bf02556354 · Cited by 69 · cited 1×
“In dogs, the administration of PGE2 increased the extent of mineralization on the bone surface of healing ribs, osteoid formation in all three envelopes, and resorption surface in the cortical endosteal envelope, indicating accelerated remodeling [20, 21].”
BackgroundKe, H. Z., Jee, W. S. S., Mori, S., Li, X. J., & Kimmel, D. B. (1992) · Calcified Tissue International · doi:10.1007/bf00296289 · Cited by 68
Is there an inhibitory effect of COX-2 inhibitors on bone healing?
Seidenberg, A. B. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.12.017 · Cited by 67
COX inhibitors and their effects on bone healing
Gerstenfeld, L. C., & Einhorn, T. A. (2004) · Expert Opinion on Drug Safety · doi:10.1517/eods.3.2.131.27335 · Cited by 67 · cited 1×
“Pro-infl ammatory stimuli and cytokine and growth factor release infl uence PG production, especially PGE2 [1, 29, 30].”
BackgroundLocal infusion of prostaglandin E1 stimulates mandibular bone formation in vivo
Marks, S. C., & Miller, S. C. (1988) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1988.tb01324.x · Cited by 66
Ho, M., Chang, J., & Wang, G. (1998) · Pharmacology · doi:10.1159/000028236 · Cited by 63 · cited 2×
“Studies have suggested that osteoblastic proliferation is involved, but not via inhibition of PG synthesis [89, 94].”
BackgroundIndomethacin-induced delayed fracture healing
Sudmann, E., & Hagen, T. (1976) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/bf00415452 · Cited by 62
Mechanical stress induces COX-2 mRNA expression in bone cells from elderly women
Joldersma, M., Burger, E. H., Semeins, C. M., & Klein‐Nulend, J. (2000) · Journal of Biomechanics · doi:10.1016/s0021-9290(99)00172-4 · Cited by 62 · cited 1×
“cells from the iliac crest of post-menopausal women have increased PGE2 and PGI2 production after fl uid shear mechanical stress [50].”
BackgroundPersson, P.-E., SODEMANN, B., & Nilsson, O. (1998) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679809117608 · Cited by 62
Effect of naproxen on cancellous bone in ovariectomized rats
Lane, N. E., Coble, T., & Kimmel, D. B. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650051006 · Cited by 60
Sakuma, Y., Li, Z., Pilbeam, C. C., Alander, C. B., Chikazu, D., Kawaguchi, H., & Raisz, L. G. (2004) · Bone · doi:10.1016/j.bone.2003.12.007 · Cited by 60 · cited 1×
“Other possible roles for PGs in bone metabolism include stimulation of cAMP production and induction of COX-2, as demonstrated in mice osteoblasts [25].”
BackgroundEffect of Local Prostaglandin E2on Fracture Callus in Rabbits
Keller, J., Klamer, A., Bak, B., & Suder, P. (1993) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679308994530 · Cited by 59 · cited 1×
“In addition, PGE2 caused a dose-dependent stimulation of callus formation in rabbits [19].”
BackgroundEffects of ketoralac tromethamine and indomethacin on primary and secondary bone healing
Reikeraas, O., & Engebretsen, L. (1998) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s004020050310 · Cited by 58
Diclofenac sodium inhibits bone resorption in postmenopausal women
Bell, N. H., Hollis, B. W., Shary, J., Eyre, D. R., Eastell, R., Colwell, A., Graham, R., & Russell, R. G. G. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90065-5 · Cited by 55
Cyclooxygenase-2 Expression in Pediatric Sarcomas
Dickens, D. S., Kozielski, R., Khan, J. I., Forus, A., & Cripe, T. P. (2002) · Pediatric and Developmental Pathology · doi:10.1007/s10024-002-0005-1 · Cited by 55 · cited 1×
“In addition, the involvement of COX-2 in other neoplasia and bone sarcomas is well documented [53, 54].”
BackgroundHeterotopic bone formation prevented by diclofenac: Prospective study of 100 hip arthroplasties
Wahlström, O., Risto, O., Djerf, K., & Hammerby, S. (1991) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679108996636 · Cited by 54
Effects of PGI2 and TxA2 analogs and inhibitors in orthodontic tooth movement.
Gürton, A. Ü., Akın, E., SAĞDIÇ, D., & ÖLMEZ, H. (2004) · PubMed · doi:10.1043/0003-3219(2004)074<0526:eoptai>2.0.co;2 · Cited by 52
Six-Year Results of a Cementless Stem With Prophylaxis Against Heterotopic Bone
Wurnig, C., Schwameis, E., Bitzan, P., & Kainberger, F. (1999) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199904000-00020 · Cited by 52
Weinreb, M., Machwate, M., Shir, N., Abramovitz, M., Rodan, G. A., & Harada, S. (2001) · Bone · doi:10.1016/s8756-3282(00)00447-6 · Cited by 51
Miyauchi, M., Hiraoka, M., Oka, H., Sato, S., Kudo, Y., Ogawa, I., Noguchi, K., Ishikawa, I., & Takata, T. (2004) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2004.04.004 · Cited by 51 · cited 2×
“Increased COX-2 expression by osteoblasts and cementoblasts has also been observed in deep periodontal tissue after application of lipopolysaccharide and in activated human articular chondrocytes [51, 55].”
BackgroundMoses, V. S., Hardy, J., Bertone, A. L., & Weisbrode, S. E. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.54 · Cited by 51 · cited 1×
“Others have demonstrated that PGE2 is markedly reduced, such as the LPS-challenged synovial explant model in equine, treated with phenylbutazone, fl unixin meglumine, ketoprofen, carprofen and meloxicam [95].”
BackgroundEffect of Ibuprofen and Indomethacin on Bone Metabolism Reflected in Bone Strength
TÖNKVIST, H., Lindholm, T. S., Netz, P., Strömberg, L., & Lindholm, T. C. (1984) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198407000-00039 · Cited by 50
Igarashi, K., Woo, J.-T., & Stern, P. H. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00861-9 · Cited by 47 · cited 1×
“For example, treatment of an in vitro neonatal mouse calvarial culture with celecoxib, a selective COX-2 inhibitor, completely, yet reversibly inhibited IL-1b-stimulated bone resorption, but not PTH-induced bone resorption [105].”
BackgroundRole of Cyclooxygenase-2 in Bone Resorption
Okada, Y., Pilbeam, C. C., Raisz, L. G., & Tanaka, Y. (2003) · Journal of UOEH · doi:10.7888/juoeh.25.185 · Cited by 47 · cited 4×
“Collectively, there is abundant evidence to support a signifi cant role of PGs in bone metabolism in health and disease, which can be modulated by exogenous administration of PGs. PGE2 and its receptors, EP2R and EP4R, appear to be the main contributors to bone metabolism.”
BackgroundInfluentialEffect of tenoxicam on fracture healing in rat tibiae
Giordano, V., Giordano, M., KNACKFUSS, I. G., Apfel, M. Í. R., & Gomes, R. D. C. (2003) · Injury · doi:10.1016/s0020-1383(02)00199-7 · Cited by 44
Lack of Effect of Indomethacin on Ordered Growth of the Femur in Rats
Sudmann, E., Tveita, T., & Hald, J. K. (1982) · Acta Orthopaedica Scandinavica · doi:10.3109/17453678208992177 · Cited by 42
Törnkvist, H., & Lindholm, T. S. (1980) · Scandinavian Journal of Rheumatology · doi:10.3109/03009748009098151 · Cited by 40
The Effect of Indomethacin on Achilles Tendon Healing in Rabbits
THOMAS, J., Taylor, D. A., Crowell, R. R., & Assor, D. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199111000-00046 · Cited by 37
Effect of diclofenac sodium on union of tibial fractures in rats
Akman, Ş., Göğüş, A., Şener, N., Bılgıç, B., Aksoy, B., & Seçkin, F. (2002) · Advances in Therapy · doi:10.1007/bf02850267 · Cited by 35
Effect of Indomethacin on Collagen Metabolism of Rat Fracture Callus in Vitro
Rø, J., Langeland, N., & Sander, J. (1978) · Acta Orthopaedica Scandinavica · doi:10.3109/17453677809050082 · Cited by 34 · cited 1×
“For example, no effects on collagen synthesis, an important marker of bone healing, were observed in vitro in rat fracture callus [101].”
BackgroundFaye-Petersen, O. M., Johnson, W. H., Carlo, W. A., Hedlund, G. L., Pacifico, A. D., & Blair, H. C. (1996) · Pediatric Pathology & Laboratory Medicine · doi:10.1080/15513819609168686 · Cited by 32 · cited 1×
“For example, infants with congenital heart disease, who are given infusions of PGE1 to maintain patency of the ductus arteriosus, exhibit striking new periosteal bone formation [49].”
BackgroundShih, M., & Norrdin, R. W. (1986) · American Journal of Veterinary Research · doi:10.2460/ajvr.1986.47.07.1561 · Cited by 31 · cited 1×
“In dogs, the administration of PGE2 increased the extent of mineralization on the bone surface of healing ribs, osteoid formation in all three envelopes, and resorption surface in the cortical endosteal envelope, indicating accelerated remodeling [20, 21].”
BackgroundJaffre, B., Pinzano, A., Lœuille, D., Gillet, P., Netter, P., Laugier, P., & Saı̈ed, A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11023 · Cited by 31
Effect of two nonsteroidal antiinflammatory drugs on heterotopic bone formation in a rabbit model
Moed, B. R., Resnick, R. B., Fakhouri, A. J., Nallamothu, B. G., & Wagner, R. A. (1994) · The Journal of Arthroplasty · doi:10.1016/0883-5403(94)90141-4 · Cited by 29
Mbugua, S. W., Skoglund, L. A., & Løkken, P. (1989) · Acta veterinaria Scandinavica · doi:10.1186/bf03548065 · Cited by 29 · cited 1×
“In a randomized placebo-controlled crossover study in Mongrel dogs, indomethacin and phenylbutazone did not affect bone healing [98].”
BackgroundOno, K., Akatsu, T., Kugai, N., Pilbeam, C. C., & Raisz, L. G. (2003) · Bone · doi:10.1016/s8756-3282(03)00264-3 · Cited by 28 · cited 2×
“Effects noted in COX-2 knockout mice included alterations of intramembranous and endochondral bone formation, suggesting a possible role of COX-2 on osteoblasts and osteoclast formation, and osteoclastogenesis, as indicated by in vitro bone marrow cell cultures [30, 37, 39].”
BackgroundComparison between the Effects of Dexamethasone and Indomethacin on Bone Wound Healing
SATO, S., KIM, T., ARAI, T., MARUYAMA, S., TAJIMA, M., & UTSUMI, N. (1986) · Japanese Journal of Pharmacology · doi:10.1254/jjp.42.71 · Cited by 27
Early effects of prostaglandin E2 on bone formation and resorption in different bone sites of rats
Lin, C. H., Jee, W. S. S., Ma, Y. F., & Setterberg, R. B. (1995) · Bone · doi:10.1016/8756-3282(95)00300-3 · Cited by 26
Bichara, J., Greenwell, H., Drisko, C. L., Wittwer, J. W., Vest, T. M., Yancey, J. M., Goldsmith, J., & Rebitski, G. (1999) · Journal of Periodontology · doi:10.1902/jop.1999.70.8.869 · Cited by 21
Obeid, G., Zhang, X., & Wang, X. (1992) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/0278-2391(92)90276-6 · Cited by 20
Prostaglandin release by normal and osteomyelitic human bones
Plotquin, D., Dekel, S., Katz, S., & Danon, A. (1991) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(91)90126-p · Cited by 16 · cited 1×
“In pathological conditions, large amounts of PGE2 have also been observed in chronic osteomyelitis and in osteoid osteoma, probably due to increased osteoblastic and osteoclastic activity [26, 27].”
BackgroundBoiskin, I., Epstein, S., Ismail, F., Fallon, M. D., & Levy, W. A. (1988) · PubMed · Cited by 16
Piroxicam-induced reduction in osteopenia after external fixation of rabbit tibia
Adolphson, P., Jonsson, U. T., & Dalén, N. (1991) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679108994471 · Cited by 4 · cited 1×
“Similarly, piroxicam did not decrease the rate of fracture healing in postmenopausal women with a displaced Colles’ fracture, but actually reduced the osteopenia caused by external fi xation [103, 104].”
BackgroundEkman, E. F., & Dahners, L. E. (2002) · The American Journal of Sports Medicine · doi:10.1177/03635465020300032601 · Cited by 2
Lu (1999) · doi:10.1002/(sici)1097-4636(199908)46:2
Cited by
Braun, J., & Sieper, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60635-7 · Cited by 1,806
Do Nonsteroidal Anti-Inflammatory Drugs Affect Bone Healing? A Critical Analysis
Pountos, I., Georgouli, T., Calori, G. M., & Giannoudis, P. V. (2012) · The Scientific World Journal · doi:10.1100/2012/606404 · Cited by 274
“and prostaglandin production, promotes differentiation of mesenchymal stem cells (MSCs) toward chondrogenic or osteogenic lineages, forming initially woven bone and in turn, the hard callus [3, 6–8].”
BackgroundNguyen, R. T., Borg‐Stein, J., & McInnis, K. (2011) · PM&R · doi:10.1016/j.pmrj.2010.11.007 · Cited by 226
“Theoretically, use of NSAIDS may impede or delay tissue healing and may even produce fibrosis [99-101].”
BackgroundNon‐Steroidal Anti‐Inflammatory Drugs, Cyclooxygenase‐2 and the Bone Healing Process
Vuolteenaho, K., Moilanen, T., & Moilanen, E. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00149.x · Cited by 191
Pharmacological agents and impairment of fracture healing: What is the evidence?
Pountos, I., Georgouli, T., Blokhuis, T. J., Pape, H. C., & Giannoudis, P. V. (2008) · Injury · doi:10.1016/j.injury.2007.10.035 · Cited by 168
Metadata
- Authors
- Radi, Z. A., & Khan, N. K.
- Affiliations
- Pfizer (United States) (US)
- Corresponding author
- Radi, Z. A.
- ORCID
- Khan, N. K.
- Venue
- Inflammation Research
- Published
- 2005-09
- Volume
- 54
- Issue
- 9
- Pages
- 358-366
- ISSN
- 1023-3830 (ISSN-L)
- 1420-908X
- OpenAlex
- W2019695236
- Cited by
- 113
- References
- 107
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 7 · 2015: 6 · 2014: 4 · 2013: 6 · 2012: 9
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Inflammation Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Tendon Structure and Treatment
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
- Keywords
- cyclooxygenase inhibition, COX-2 inhibitors, non-selective NSAIDs, prostaglandins, arachidonic acid metabolism, bone regeneration, fracture healing, tendon healing, ligament healing, orthopedic surgery, postoperative analgesia
- MeSH terms
- Animals, Bone and Bones, Humans, Ligaments, Tendons, Wound Healing, Cyclooxygenase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.